On December 23, Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort EP") 's new product, Transseptal Guiding Introducer and the accessories, completed its first clinical case observation in the General Hospital of Shenyang Military Region. Compared with similar imported products, the surgeon's evalsuation of the product was very good.
The product is independently researched and developed by MicroPort EP, and it's an essential for the catheter ablation of atrial fibrillation surgery, guiding radiofrequency catheter ablation and mapping catheter to a desired locations in the surgery. This time's clinical observation mainly studies the safety and effectiveness of the product, and the achievement indicates MicroPort EP takes a step forward for providing a systematic solution for the treatment of complex arrhythmia.